yttrium/סרקומה

הקישור נשמר בלוח

בחר סוג מיון

עמוד 1 מ 20 תוצאות

Response and Overall Survival for Yttrium-90 Radioembolization of Hepatic Sarcoma: A Multicenter Retrospective Study.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

To evaluate the effectiveness and safety of yttrium-90 transarterial radioembolization (TARE) for the treatment of primary and metastatic soft tissue sarcoma (STS) of the liver. A retrospective review of 39 patients with primary (n = 2) and metastatic (n = 37) hepatic STS treated with TARE at 4

Nodular Classic Kaposi's Sarcoma Treated With Neodymium-Doped Yttrium Aluminum Garnet Laser Delivered Through a Tilted Angle: Outcome and 12-Month Follow Up.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Classic Kaposi's sarcoma (KS) is a multifocal angioproliferative disorder with a long and indolent course typically affecting the lower extremities of elderly men. Multiple nodules with a rapid growth may sometimes develop, causing pain, bleeding, and discomfort on walking. In such

Successful Treatment of Classic Kaposi Sarcoma With Long-Pulse Neodymium-Doped Yttrium Aluminum Garnet Laser: A Preliminary Study.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND Kaposi sarcoma (KS) is a systemic disease that can present with cutaneous lesions with or without internal involvement, mostly caused by infection with human herpesvirus-8. The treatment options include surgical excision, cryotherapy, radiotherapy, intralesional chemotherapy, laser, and

[APROPOS OF SARCOMAS INDUCED BY YTTRIUM AT THE SITE OF INJECTION IN RATS].

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Preoperative irradiation of osteogenic sarcoma with intra-arterially injected yttrium-90 microspheres. Case report.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

OBJECTIVE To evaluate Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status as a prognostic factor for survival after yttrium-90 ((90)Y) radioembolization for colorectal cancer (CRC) liver metastases. METHODS Consecutive patients with unresectable CRC liver metastases and documented KRAS

Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Most countries still do not achieve 1 IU of factor VIII/capita sufficient for survival. Although primary prophylaxis prevents synovitis, is not universally used. Chronic synovitis is treated with arthroscopy at expense of considerable amount of coagulation factors, and specialized surgeons.

Basophilic round bodies in gastric biopsies little known by pathologists: iatrogenic yttrium 90 microspheres deriving from selective internal radiation therapy.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Selective internal radiation therapy is a relatively new technique that irradiates primary and metastatic liver cancer using yttrium 90 microspheres. Increasing reports have shown this to be a useful treatment for unresectable primary hepatocellular carcinoma and others metastases from colon, lung,

Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND Unresectable hepatic metastases from aerodigestive cancers are common and in most cases herald a poor prognosis. A small percentage of patients maybe amenable to surgical resection or ablation once the biology of the disease and the burden of hepatic disease are better understood. The use

Synchronous evaluation of toxico- and pharmaco-dynamics of yttrium-90 by a novel autoradiographic procedure.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

A synchronous evaluation was performed, using a quick in vivo [2-(14)C]thymidine labeling method, of the toxico- and pharmaco-dynamics of a given dose of yttrium-90 (90Y) at a given time after injection to nude BALB/c mice loaded with 10(7) HuO9 cells. Quantitative data were 14C-microautoradiographs

Direct Interstitial Treatment of Solid Tumors Using an Injectable Yttrium-90-Polymer Composite.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Purpose: Yttrium-90 (⁹⁰Y)-polymer composite (radiogel) may be administered directly into cancerous tissues to deliver highly localized beta radiation for therapy. In a dose-escalation study, the authors investigated the feasibility of treating feline and canine soft-tissue sarcomas

Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Purpose: To assess the safety and effectiveness of yttrium-90 radioembolization and checkpoint inhibitor immunotherapy within a short interval for the treatment of unresectable hepatic metastases.

Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10.
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם

We previously reported Frizzled homolog 10 (FZD10), a member of the Frizzled family, to be a promising therapeutic target for synovial sarcomas. In this report, we established a murine monoclonal antibody (MAb), namely, MAb 92-13 that had specific binding activity against native FZD10 product

Successful use of transarterial radioembolization with yttrium-90 (TARE-Y90) in two children with hepatoblastoma
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם

Primary malignant liver tumors are rare but all require surgical resection as part of therapy with curative intent. A minority of patients have resectable tumors at diagnosis. Chemotherapy has a therapeutic role in hepatoblastoma but only one-third of patients have resectable disease at diagnosis.

Yttrium-90 radiation segmentectomy for hepatic metastases: A multi-institutional study of safety and efficacy
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם

Background and objectives: This study assessed the outcomes of Yttrium-90 (⁹⁰ Y) radiation segmentectomy for hepatic metastases unamenable to resection or ablation. Materials and methods:

קודם
1
2
הַבָּא

הצטרפו לדף הפייסבוק שלנו

Herbal & Natural Medicine
המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע
עובד ב 55 שפות
מרפא צמחי מרפא מגובה על ידי מדע
זיהוי עשבי תיבול על ידי דימוי
מפת GPS אינטראקטיבית - תייגו עשבי תיבול במיקום (בקרוב)
קרא פרסומים מדעיים הקשורים לחיפוש שלך
חפש עשבי מרפא על פי השפעותיהם
ארגן את תחומי העניין שלך והתעדכן במחקר החדשות, הניסויים הקליניים והפטנטים
הקלד סימפטום או מחלה וקרא על צמחי מרפא שעשויים לעזור, הקלד עשב וראה מחלות ותסמינים שהוא משמש נגד.
* כל המידע מבוסס על מחקר מדעי שפורסם

yttrium/סרקומה

Response and Overall Survival for Yttrium-90 Radioembolization of Hepatic Sarcoma: A Multicenter Retrospective Study.

Nodular Classic Kaposi's Sarcoma Treated With Neodymium-Doped Yttrium Aluminum Garnet Laser Delivered Through a Tilted Angle: Outcome and 12-Month Follow Up.

Successful Treatment of Classic Kaposi Sarcoma With Long-Pulse Neodymium-Doped Yttrium Aluminum Garnet Laser: A Preliminary Study.

[APROPOS OF SARCOMAS INDUCED BY YTTRIUM AT THE SITE OF INJECTION IN RATS].

Preoperative irradiation of osteogenic sarcoma with intra-arterially injected yttrium-90 microspheres. Case report.

KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.

Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety.

Basophilic round bodies in gastric biopsies little known by pathologists: iatrogenic yttrium 90 microspheres deriving from selective internal radiation therapy.

Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.

Synchronous evaluation of toxico- and pharmaco-dynamics of yttrium-90 by a novel autoradiographic procedure.

Direct Interstitial Treatment of Solid Tumors Using an Injectable Yttrium-90-Polymer Composite.

Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases

Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10.

Successful use of transarterial radioembolization with yttrium-90 (TARE-Y90) in two children with hepatoblastoma

Yttrium-90 radiation segmentectomy for hepatic metastases: A multi-institutional study of safety and efficacy

המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע